Lee Gary K. (CIK 1907345) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-25). Recent activity: Sell LYEL (1,457 shares), Sell LYEL (131 shares), Sell LYEL (130 shares), Sell LYEL (1,671 shares), Buy LYEL (4,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 1,457 | $22,642 |
| 2026-08-11 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 131 | $1,879 |
| 2026-06-15 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 130 | $2,460 |
| 2026-02-12 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 1,671 | $39,085 |
| 2026-02-11 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Buy | 4,000 | $0 |
| 2026-02-11 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 147 | $3,399 |
| 2025-11-12 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 138 | $2,230 |
| 2025-08-22 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Buy | 8,000 | $0 |
| 2025-08-22 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 1,453 | $15,315 |
| 2025-08-13 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 131 | $1,379 |
| 2025-08-13 | Lyell Immunopharma, Inc. (LYEL) | Chief Scientific Officer | Sell | 136 | $1,406 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25